With annual revenue of $50.3bn and an R&D expenditure of $9.3bn, this Swiss multinational healthcare company has one of the highest R&D spends.
It owns several companies through acquisitions and aims to expand its presence in different areas through acquisitions in pharmaceutical and diagnostics. Hoffmann-La Roche has approx 88500 employees across the world. It covers various disease areas oncology, neuroscience, infectious diseases, immunology, cardiovascular etc.
It has three business areas pharmaceuticals, diagnostics and researchers. The company Hoffmann-La Roche was founded in 1896. It is headquartered in Basel, Switzerland.